# Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)

> **NCT00898677** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1268 (actual)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** rizatriptan benzoate
- **DRUG:** rizatriptan benzoate
- **DRUG:** Comparator: sumatriptan
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT00898677
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-09
- **Primary completion:** 1996-05
- **Final completion:** 1996-09
- **Target enrollment:** 1268 (ACTUAL)
- **Last updated:** 2022-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898677, "Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT00898677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*